Разработки

Drugs INN Discovery Preclinical Phase I Phase II Phase III Reg&Comm
Novel drugs
AURIXIM Rituximab conjugate
BI-CON-02 Trastuzumab conjugate
Generic
NESCLER Fingolimod Bioequivalence studies
Biosimilars
RITUMAX Rituximab
BI-MAB-03 Trastuzumab
BI-MAB-02 Bevacizumab